GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Cyclically Adjusted FCF per Share

JW Pharmaceutical (XKRX:001060) Cyclically Adjusted FCF per Share : ₩1,203.27 (As of Mar. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

JW Pharmaceutical's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩1,251.570. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩1,203.27 for the trailing ten years ended in Mar. 2024.

During the past 12 months, JW Pharmaceutical's average Cyclically Adjusted FCF Growth Rate was 40.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 18.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of JW Pharmaceutical was 286.70% per year. The lowest was 18.60% per year. And the median was 152.65% per year.

As of today (2024-06-05), JW Pharmaceutical's current stock price is ₩29600.00. JW Pharmaceutical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩1,203.27. JW Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is 24.60.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of JW Pharmaceutical was 1908.79. The lowest was 20.04. And the median was 37.65.


JW Pharmaceutical Cyclically Adjusted FCF per Share Historical Data

The historical data trend for JW Pharmaceutical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Cyclically Adjusted FCF per Share Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.96 573.84 914.43 807.50 956.22

JW Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 859.42 722.66 954.20 956.22 1,203.27

Competitive Comparison of JW Pharmaceutical's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Pharmaceutical's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Cyclically Adjusted Price-to-FCF falls into.



JW Pharmaceutical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JW Pharmaceutical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1251.57/118.8477*118.8477
=1,251.570

Current CPI (Mar. 2024) = 118.8477.

JW Pharmaceutical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -373.782 99.353 -447.124
201409 214.631 99.608 256.088
201412 487.432 99.098 584.575
201503 -1,009.038 99.720 -1,202.586
201506 954.362 100.050 1,133.670
201509 -366.976 100.110 -435.663
201512 372.905 100.220 442.216
201603 -65.260 100.560 -77.128
201606 504.057 100.790 594.365
201609 -665.706 101.460 -779.791
201612 145.741 101.560 170.549
201703 332.635 102.850 384.374
201706 36.181 102.610 41.907
201709 562.274 103.490 645.714
201712 19.292 102.990 22.262
201803 -1,047.850 104.100 -1,196.297
201806 1,226.135 104.130 1,399.437
201809 1,631.675 105.650 1,835.502
201812 -425.448 104.350 -484.557
201903 -74.578 104.490 -84.826
201906 450.242 104.880 510.204
201909 338.955 105.200 382.928
201912 995.130 105.120 1,125.085
202003 -26.278 105.540 -29.591
202006 120.926 104.870 137.044
202009 1,468.964 106.200 1,643.908
202012 343.856 105.765 386.388
202103 -819.378 107.357 -907.076
202106 -93.579 107.579 -103.382
202109 768.511 108.759 839.798
202112 378.813 109.676 410.490
202203 77.591 111.806 82.478
202206 236.705 114.083 246.591
202209 577.119 114.831 597.305
202212 810.233 115.200 835.887
202303 -578.855 116.550 -590.269
202306 342.641 117.140 347.636
202309 1,236.300 119.111 1,233.565
202312 829.409 118.848 829.409
202403 1,251.570 118.848 1,251.570

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


JW Pharmaceutical  (XKRX:001060) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

JW Pharmaceutical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=29600.00/1203.27
=24.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of JW Pharmaceutical was 1908.79. The lowest was 20.04. And the median was 37.65.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


JW Pharmaceutical Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical (XKRX:001060) Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines